The HealthTree News for Myeloma is a place to learn all about Myeloma in easy-to-understand language. The site features news articles, patient stories, Myeloma basics articles, and clinical trial updates with new content every week.
Jan. 24, 2023
ASH 2022: A New Option for High-Risk Smoldering Myeloma Patients
Jan. 24, 2023
ASH 2022: Talquetamab for Relapsed/Refractory Myeloma Showing Durable Responses
Jan. 22, 2023
ASH 2022: Improved Quality of Life on Quad Therapy
Jan. 22, 2023
Starting Your Myeloma Journal
Jan. 19, 2023
ASH 2022: Elranatamab Bispecific Shows Promise in Multiple Myeloma
Jan. 19, 2023
ASH 2022: New Bispecific Combinations Studied in Relapsed/Refractory Myeloma
Jan. 18, 2023
Save the Date(s): Austin, Indianapolis, Raleigh-Durham Myeloma Round Tables, Spring 2023
Jan. 17, 2023
ASH 2022: Faster, More Effective CAR T in Development by BMS for Multiple Myeloma
Jan. 17, 2023
What is Plasma Cell Enrichment and How Does it Help Obtain Better Test Results in Multiple Myeloma?
Jan. 16, 2023
ASH 2022: The MRD2STOP Study Could Change the Face of Maintenance
Jan. 12, 2023
ASH 2022: Cancer Causes Distress. No Duh!
Jan. 09, 2023
ASH 2022: Factors Influencing Black Patient Participation in Clinical Trials
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.